Trademark Overview
On Friday, May 17, 2024, a trademark application was filed for KESMALEA with the United States Patent and Trademark Office. The USPTO has given the KESMALEA trademark a serial number of 98555977. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, December 4, 2024. This trademark is owned by Kesmalea Therapeutics Limited. The KESMALEA trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signalling, detecting, testing, inspecting, life-saving and teaching apparatus and instruments; software; software for use in scientific and/or pharmaceutical research and development; software for scientific modelling; software for pharmaceutical modelling; software for research and development in the field of oncology, immunology and central nervous system disease; software for the managing, analysis, and visualisation of biological data; devices for analysing protein sequence used as laboratory apparatus
Pharmaceutical preparations; pharmaceutical preparations, in particular, chemical and biological preparations for medical purposes; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment or prevention of disorders or diseases caused by bacteria; biological preparations for the treatment of cancer; biological preparations for the treatment of viral infections; biological preparations for the treatment of autoimmune diseases; biological preparations for the treatment of central nervous system diseases; biological preparations for medical use; immunotherapeutic drugs; reagents for medical use; diagnostic preparations; diagnostic reagents for medical use; protein synthesis inhibitors, none of the foregoing relating to preparations for the treatment of central nervous system diseases and disorders
Proteins for use in science; regulatory proteins for scientific and medical use; chemical reagents for use in biotechnology, other than for medical or veterinary use
Medical services; medical analysis services; oral medical care services; medical diagnostic services; diagnostic and prognostic medical services; advisory services relating to medical services; medical screening and assaying; medical services in the field of oncology and immunotherapy; pharmacy advice; medical and health services relating to antibodies, immuno-oncology, inflammation, haematology, central nervous system and infectious disease; medical screening and assaying
Surgical, medical, dental and veterinary apparatus and instruments; medical devices; apparatus for drug administration; diagnostic apparatus for the detection of abnormal prion protein
Scientific, medical and technological services and research and design relating thereto; research relating to molecular sciences; analysis in the field of molecular biology; drug discovery services; clinical research; medical research; biological research; research relating to pharmaceuticals; pharmaceutical research and development; development of pharmaceutical preparations and medicines; platform as a service [PaaS]; platform as a service [PaaS] featuring medical analysis software; software as a service [Saas]; software as a service [Saas] featuring medical analysis software; provision of non-downloadable software for the management, visualisation and analysis of biological data for the purposes of biomolecular research and the design and engineering of biomolecular products; biotechnology research; biotechnology testing; research and development in the pharmaceutical and biotechnology fields; scientific screening and assaying; chemical analysis; chemical research; medical research ...
